Overall Survival, Costs and Healthcare Resource Use by Number of Regimens Received in Elderly Patients with Newly Diagnosed Metastatic Triple-Negative Breast Cancer
Overall Survival, Costs and Healthcare Resource Use by Number of Regimens Received in Elderly Patients with Newly Diagnosed Metastatic Triple-Negative Breast Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Overall Survival, Costs and Healthcare Resource Use by Number of Regimens Received in Elderly Patients with Newly Diagnosed Metastatic Triple-Negative Breast Cancer have?
Overall Survival, Costs and Healthcare Resource Use by Number of Regimens Received in Elderly Patients with Newly Diagnosed Metastatic Triple-Negative Breast Cancer has 30 citations in the OpenAlex counts ScholarIQ stores.
When was Overall Survival, Costs and Healthcare Resource Use by Number of Regimens Received in Elderly Patients with Newly Diagnosed Metastatic Triple-Negative Breast Cancer published?
Overall Survival, Costs and Healthcare Resource Use by Number of Regimens Received in Elderly Patients with Newly Diagnosed Metastatic Triple-Negative Breast Cancer has 2019 year in the ScholarIQ index.
What is the open-access status of Overall Survival, Costs and Healthcare Resource Use by Number of Regimens Received in Elderly Patients with Newly Diagnosed Metastatic Triple-Negative Breast Cancer?
Overall Survival, Costs and Healthcare Resource Use by Number of Regimens Received in Elderly Patients with Newly Diagnosed Metastatic Triple-Negative Breast Cancer has hybrid oa status in the ScholarIQ index.
What is the DOI of Overall Survival, Costs and Healthcare Resource Use by Number of Regimens Received in Elderly Patients with Newly Diagnosed Metastatic Triple-Negative Breast Cancer?
The DOI for Overall Survival, Costs and Healthcare Resource Use by Number of Regimens Received in Elderly Patients with Newly Diagnosed Metastatic Triple-Negative Breast Cancer is on the source record.
What is the PMID of Overall Survival, Costs and Healthcare Resource Use by Number of Regimens Received in Elderly Patients with Newly Diagnosed Metastatic Triple-Negative Breast Cancer?
The PMID for Overall Survival, Costs and Healthcare Resource Use by Number of Regimens Received in Elderly Patients with Newly Diagnosed Metastatic Triple-Negative Breast Cancer is on the source record.
What is the OpenAlex record for Overall Survival, Costs and Healthcare Resource Use by Number of Regimens Received in Elderly Patients with Newly Diagnosed Metastatic Triple-Negative Breast Cancer?
The OpenAlex for Overall Survival, Costs and Healthcare Resource Use by Number of Regimens Received in Elderly Patients with Newly Diagnosed Metastatic Triple-Negative Breast Cancer is on the source record.